OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

6 Projects | 3 Researchers | $587,987 Invested

2010

Buck Institute for Research on Aging

Varghese John, PhD

Identification of inhibitors for the C-terminal D664 cleavage of APP as potential therapeutic agents for Alzheimer's Disease

  • Funding Amount: $115,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2008

Buck Institute for Research on Aging

Varghese John, PhD

Identification of Inhibitors for the C-Terminal D664 Cleavage of APP as Potential Therapeutic Agents for Alzheimer's Disease

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

Buck Institute for Research on Aging

Dale Bredesen, PhD

Screening for Alzheimer's Therapeutics Based on a Novel Target

  • Funding Amount: $50,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2004

Buck Institute for Research on Aging

Dale Bredesen, PhD

Screening for Alzheimer's Therapeutics Based on a Novel Target

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2002

Buck Institute for Research on Aging

Dale Bredesen, PhD

Development of Drugs for a New Therapeutic Target in Alzheimer's Disease

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

Buck Institute for Research on Aging

Simon Melov, PhD

Potential Therapeutics for Alzheimer's Disease

  • Funding Amount: $97,987
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed